Two scientists-turned-entrepreneurs have created the technology platform S-TIR for immunology vaccines, enabling treatments for allergies and cancer. Based on their strong patent portfolio they founded several start-up companies for product development and technology commercialisation. In this podcast they explain how IP was essential for attracting investment as well as generating licensing revenue early on. This was crucial given the long time-to-market periods that are typical in biotechnology.

The EPO has recently published three new case studies highlighting the role of IP in creating businesses that are bringing technologies to market to diagnose and/or treat cancer.

Download the case studies: https://www.epo.org/learning/materials/sme/innovation-case-studies/technology-transfer-case-studies.html